SCHEMBL19036704

SCHEMBL19036704

N/C(=C\S)c1ccc(N2CCOCC2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.53
▸ HPGD P15428 2/20 0.53
▸ KDM4E B2RXH2 2/20 0.53
▸ ALOX15 P16050 1/20 0.53
▸ HSD17B10 Q99714 1/20 0.53
▸ GSK3B P49841 1/20 0.53
▸ MAOB P27338 1/20 0.49
▸ MAPT P10636 9/20 0.47
▸ HDAC8 Q9BY41 2/20 0.47
▸ HDAC6 Q9UBN7 2/20 0.47
▸ HDAC3 O15379 1/20 0.47
▸ HDAC4 P56524 1/20 0.47
▸ HDAC1 Q13547 1/20 0.47
▸ HDAC7 Q8WUI4 1/20 0.47
▸ HDAC2 Q92769 1/20 0.47
▸ HDAC10 Q969S8 1/20 0.47
▸ HDAC11 Q96DB2 1/20 0.47
▸ HDAC9 Q9UKV0 1/20 0.47
▸ HDAC5 Q9UQL6 1/20 0.47
▸ NPC1 O15118 7/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15075762 0.84 ALDH1A1 (0.51) ALDH1A1HPGDKDM4EALOX15HSD17B10
SCHEMBL1397706 0.80 GSK3B (0.62) ALDH1A1HPGDKDM4EALOX15HSD17B10
SCHEMBL24164412 0.80 GSK3B (0.62) ALDH1A1HPGDKDM4EALOX15HSD17B10
Hydrochloric Acid SCHEMBL16209943 0.79 GSK3B (0.60) ALDH1A1HPGDKDM4EALOX15HSD17B10
Bromide SCHEMBL27592745 0.79 GSK3B (0.60) ALDH1A1HPGDKDM4EALOX15HSD17B10
SCHEMBL4518566 0.77 HPGD (0.47) ALDH1A1HPGDKDM4EALOX15MAPT
SCHEMBL12291909 0.77 HPGD (0.60) ALDH1A1HPGDKDM4EALOX15MAPT
SCHEMBL26474835 0.77 F2 (0.78) ALDH1A1HPGDKDM4EALOX15HSD17B10
SCHEMBL15285555 0.77 ALDH1A1 (0.68) ALDH1A1HPGDKDM4EALOX15HSD17B10
SCHEMBL2742813 0.76 NPC1 (0.66) ALDH1A1HPGDKDM4EALOX15HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190194202-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CHEMICAL WARFARE AGENT-INDUCED INJURIES ELI LILLY AND COMPANY 2019-06-27 — — US disclosed
US-9951073-B2 Compounds and compositions for treating chemical warfare agent-induced injuries HYDRA BIOSCIENCES, INC. (US) 2018-04-24 — — US disclosed
EP-3184527-A1 2,6-DIOXO,-2,3-DIHYDRO-1H-PURINE COMPOUNDS USEFUL FOR TREATING DISORDERS RELATED TO THE ACTIVITY OF THE TRPA1 CHANNEL Hydra Biosciences, Inc. (US) 2017-06-28 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190194202-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CHEMICAL WARFARE AGENT-INDUCED INJURIES ELANE, CASP3, MMP8 ALDH1A1 1104/4885HPGD 1082/4885KDM4E 4024/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback